Matthew J. Klebanoff, MD, MSHP
Assistant Professor of Medicine (General Internal Medicine)
Internal Medicine Physician, Hospital of the University of Pennsylvania, Philadelphia, PA
Internal Medicine Physician, Penn Presbyterian Medical Center, Philadelphia, PA
Affiliated Faculty, Center for Health Incentives and Behavioral Economics/Penn Roybal Center
Internal Medicine Physician, Perelman Center for Advanced Internal Medicine
Senior Fellow, Leonard Davis Institute of Health Economics, Philadelphia, PA
Department: Medicine
Contact information
3600 Civic Center Boulevard, Office 7-207
Philadelphia, PA 19104
Philadelphia, PA 19104
Office: 516-655-9537
Publications
Education:
AB (Geological Sciences)
Brown University, Providence, RI, 2012.
MD
Yale School of Medicine, 2020.
MSHP (Health Policy)
University of Pennsylvania, Philadelphia, PA, 2025.
Permanent linkAB (Geological Sciences)
Brown University, Providence, RI, 2012.
MD
Yale School of Medicine, 2020.
MSHP (Health Policy)
University of Pennsylvania, Philadelphia, PA, 2025.
Selected Publications
Ashok V, Yun K, Klebanoff M, Kaufman E, Aysola J, Richmond T: Characteristics Associated with Community Violence Prevention Programs in US Hospitals: A Cross-Sectional Survey Analysis. Academic Emergency Medicine. 2026 (Under Revision).Doshi JA, Klebanoff MJ, Merchant M, Li P, Kazi DS: Trends in Utilization, Spending, and Coverage for PCSK9 Inhibitors in Medicare Part D. American College of Cardiology Annual Scientific Session. 2026 (Accepted Poster Presentation).
Klebanoff MJ, Li P, Long JA, Doshi JA: Medicare Part D Coverage and Costs for Glucagon-Like Peptide-1 Receptor Agonists. JAMA. 334(20): 1848-1850, Nov 25 2025.
Klebanoff MJ, Chetty AK, Doshi JA: Medicaid Coverage and Prior Authorization for Antiobesity Glucagon-Like Peptide-1 Receptor Agonists: A Cross-Sectional Study of State Policies. J Gen Intern Med. Page: (Online ahead of print), Nov 21 2025.
Li P, Lin JK, Klebanoff MJ, Palkar R, Chahin S, Doshi JA: Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple Sclerosis. Neurol Clin Pract. 15(6): e200536, Sep 16 2025.
Doshi JA, Li P, Klebanoff MJ, Lin JK: Inflation Reduction Act Provisions and Medicare Part D Out-of-Pocket Costs for Specialty Drugs. JAMA Health Forum. 6(5), May 2 2025.
Klebanoff MJ, Chetty AK, Doshi JA: Prior Authorization Policies for Antiobesity GLP-1 Agonists across State Medicaid Programs. Society of General Internal Medicine Annual Meeting. 2025.
Klebanoff MJ, Li P, JA Long, Doshi JA: Trends in Medicare Part D Formulary Coverage, Prior Authorization, and Out-of-Pocket Costs for Glucagon-like Peptide-1 Receptor Agonists, 2020-2025. AcademyHealth Annual Research Meeting (Podium Presentation). 2025.
Klebanoff MJ, Li P, Chatterjee P, Doshi JA: Real-time Prescription Benefit Tool Adoption Among U.S. Hospitals. JAMA Health Forum. 5(10): e243181, Oct 4 2024.
Klebanoff MJ, Li P, Lin JK, Doshi JA: Formulary Coverage of Brand-Name Adalimumab and Biosimilars Across Medicare Part D Plans. JAMA. 332(1): 74-76, Jul 2 2024.